Capricor Therapeutics CAPR EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Capricor Therapeutics’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's EV / sales?
- Capricor Therapeutics (CAPR) reported EV / sales of 29.2× in Q3 2025.
- How has Capricor Therapeutics's EV / sales changed year-over-year?
- Capricor Therapeutics's EV / sales increased by 42.9% year-over-year, from 20.4× to 29.2×.
- What is the long-term trend for Capricor Therapeutics's EV / sales?
- Over 2 years (2020 to 2024), Capricor Therapeutics's EV / sales has grown at a -58.6% compound annual growth rate (CAGR), from 161.9× to 27.7×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.